ArticleJornal de pediatria2026
Cost-effectiveness of oral food challenge in managing cow's milk allergy under the Brazilian Public Health perspective.
Article in Jornal de pediatria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the cost-effectiveness and cost-utility of using oral food challenge test (OFC) to manage non-IgE-mediated gastrointestinal cow's milk protein allergy (non-IgE-GI-CMPA) in infants within the Brazilian public health system (SUS).
methodA decision model was developed to compare two strategies: 1. GUIDELINE-OFC: 100 % of physicians recommending OFC for diagnosis (D-OFC) and evaluation of oral tolerance (OT-OFC), and 2. REAL-WORLD-OFC: OFC performed according to the practices of pediatricians in Brazil (D-OFC indicated by 56 % and 45 % of physicians for mild-to-moderate and severe cases, respectively, and OT-OFC indicated by 93 % of physicians for both cases). The authors assumed that 10 % of parents would refuse the OFC and set the ages of 3.65 and 24 months for model admission and follow-up (time horizon), respectively. Clinical and epidemiological data, primarily from Brazil, data on public health costs, and a 5 % discount rate for both costs and outcomes were used. The effectiveness endpoint was the duration without a cow's milk elimination diet and quality-adjusted life-year (QALY) values of 0.84 (with allergy) and 0.94 (without allergy).
resultsGUIDELINE-OFC resulted in average savings of USD 241.98, a gain of +0.019 QALYs, and +70 days without a cow's milk elimination diet per patient. In the probabilistic sensitivity analysis, all cost-effectiveness and 96.5 % of cost-utility simulations demonstrated lower costs and greater effectiveness. Over five years, the public healthcare system would save USD 129 million.
conclusionsUsing OFC in infants with non-IgE-GI-CMPA is a dominant strategy, yielding substantial savings for the SUS and potentially improving nutritional status and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.